VentureFriends is a venture capital fund that invests in tech-enabled companies. VentureFriends (VF) is a venture capital fund specialising in seed stage startups. VF seeks to invest in tech-enabled B2C and B2B startups that can develop a sustainable moat over time and have a sweet spot for PropTech, FinTech, Marketplaces, and SaaS. The fund typically invests between €0.3M - €2.5M and can follow on up to a total of €5 - 10M. VentureFriends invests predominantly in Europe and is founded by ex-entrepreneurs and angel investors, thus having an entrepreneurial and founder-friendly philosophy.

VentureFriends

Crowberry Capital invests at seed and early stage in outstanding teams building global businesses around true technology advantages. They work with their teams to build fast paced, international companies from the Nordics. They have a strong follow through philosophy. They back the best from seed to exit. The founding partners behind Crowberry Capital have worked together for over 7 years. The Crowberry team has managed over 51 technology start-ups, negotiated a total of 15 exits and made 17 seed investments. The Crowberry team has a Global outlook having lived and worked in a total of 8 countries on 4 continents.

Crowberry Capital

Seed Capital invests in Danish tech businesses with global ambitions. We are focused on ''late seed''-stage companies, typically investing 2-4 MEUR in rounds of 2-10 MEUR. Proud backers of Trustpilot, Vivino, Lunar, Templafy, Dixa, Forecast, and many other great companies.

Seed Capital

Inovo.vc invests up to €4M in founders from Central and Eastern Europe all over the world. Since 2014, we've invested in over 50 startups - we’re early investors in, e.g. Booksy, Preply Spacelift or Infermedica. Our startups raised over €500M from funds like Insight Partners, a16z or Gradient. We raised our third €107M fund in 2022.

Inovo.vc

We are a first-money and incubation investor.  We partner with people with whom we share a vision, and work together to figure out how to get there. We will never say “come back when you have traction”. If we like the WHY and the WHO, the WHAT and HOW is what we figure out together.

Founders

Embla

Embla provides an online medical weight loss treatment using prescription drugs and coaching. The company provides patients with evidence-based treatments, digital tools, medication, and coaching to facilitate sustainable weight loss. Embla was founded in 2021 and is headquartered in Copenhagen, Denmark.

<div>Denmark-based Embla provides virtual weight loss services via online consultations, coaching, and medication management. The company offers its services online via its app, which allows for virtual consultations with doctors, nurses, and coaches, who help users make lifestyle changes to help them lose weight. The app additionally includes access to community boards, educational material, recipes, and tracking functions for sleep, diet, and mental status. For users with body mass indices (BMI) over 30, the company prescribes weight loss medication, after completing a full background screening to exclude users who are pregnant and/or are addicted to alcohol or drugs. Once the weight loss medication is prescribed, users can collect their medication from local pharmacies.&nbsp;</div>

More important now than ever, telehealth will long outlast the pandemic that drove its growth.

Telehealth

<div>
 
 Denmark-based Embla provides virtual weight loss services via online consultations, coaching, and medication management. The company offers its services online via its app, which allows for virtual consultations with doctors, nurses, and coaches, who help users make lifestyle changes to help them lose weight. The app additionally includes access to community boards, educational material, recipes, and tracking functions for sleep, diet, and mental status. For users with body mass indices (BMI) over 30, the company prescribes weight loss medication, after completing a full background screening to exclude users who are pregnant and/or are addicted to alcohol or drugs. Once the weight loss medication is prescribed, users can collect their medication from local pharmacies.&nbsp;
 
 
 The company operates on a subscription basis, charging users GBP 34.50 per month for its basic weight loss program, GBP 45 per month for its limited medication-assisted weight loss program, and GBP 249 for its full medication-assisted weight loss program. The company operates across both Denmark and the UK.
 
 
 
 
 Funding and financials
 
 
 In August 2023, the company raised EUR 10 million (USD 10.9 million) in a Series A funding round co-led by Seed Capital and Inovo VC, along with participation from other venture capital firms. The raised funds were set aside to roll out its app in the UK, add AI-based features to help provide customized treatments, and hire 20&ndash;30 staff in 2024. The funds were to also be used to begin planning the company&rsquo;s expansion into the US.
 
</div>

<div>
 
 Nice Healthcare is a US based telehealth company with a focus on primary care services to business-to-business (B2B) clients. Once the employer signs its employees with Nice (at a cost of USD 30 to USD 36 per employee per month), employees do not have to incur out of pocket expenses for Nice services and can schedule virtual or home visits within the time frames specified by the company. It connects patients with practitioners through a mobile app over video calls or text messages. Members can also request home visits which will be completed within a few hours, as claimed by the company. As of March 2022, Nice was operating in twelve states, and had over 400 small and medium enterprises (SMEs).
 
 
 In March 2022, the company raised USD 30 million in Series A financing led by DNA Capital which has been earmarked to expand its platform&rsquo;s reach among small and medium businesses. Additionally, the company is hiring three members for its management team to support the continuing growth of the organization.
 
 
 
</div>

Nice Healthcare

Amicomed is a cloud-based Software-as-a-Service (SaaS) platform which provides blood pressure monitoring services. It collects blood pressure data of patients from at-home devices, applies algorithms, and assesses the fluctuations in the blood pressure. Physicians can be connected and provided with blood pressure data of their patients in order to facilitate their workload, enabling more personalized management of patients regarding medication and lifestyle indications.Amicomed can also recommend actionable and personalized lifestyle interventions such as daily diet and exercises via virtual coaching.

Amicomed

Winston is a men’s health telemedicine platform that treats common issues impacting men such as sexual problems, hair loss, acne, and cold sores. Winston allows patients to consult doctors, place orders for prescription drugs, and offers free delivery to the homes of patients.The Toronto-based company aims to avoid men deferring doctor visits or withholding sensitive information. The consultation fee is covered by the provincial health plan, but the prescriptions are billed to the customer.

Winston

<div>
 
 Dialogue partners with employers and health insurers to offer telehealth services to their employees and members. The users have 24/7 access to doctors, nurses, and other healthcare professionals via audio, video, and chat options for wide arrays of physical and mental health needs, artificial intelligence-enabled (AI-enabled) triage, referrals, and prescription renewals. 
 
 
 The company launched its trademarked Integrated Health Platform in January 2021 to consolidate its virtual care, wellness programs, mental healthcare services, and Employee Assistance Program (EAP) onto a single platform. The company claims to be the only integrated health and wellness B2B platform in Canada. 
 
 
 Key Customers and partnerships
 
 
 Dialogue had direct relationships with over 2,000 customers across Canada and Germany as of December 2020 and served around 50,000 organizations through these partnerships. In addition, the number of members with access to the virtual platform topped 1 million in January 2021. 
 
 
 Fundings and financials
 
 
 As of March 2021, Dialogue was planning to raise CAD 100 million (USD 80 million) from an initial public offering that will be listed on the Toronto Stock Exchange under the ticker symbol &ldquo;CARE.&rdquo; 
 
 
 In Q2 2023, net losses reduced significantly YoY to CAD 5.8 million (USD 4.3 million) from CAD 8.4 million (USD 6.3 million) in Q2 2022. Top-line revenue met internal expectations, growing 17.2% YoY to CAD 25.5 million (USD 19.0 million), driven by &nbsp;an increase in new members (by 18.6% YoY), 
 an expansion of the attach rate as existing customers added more services, and full-quarter contributions from Tictrac.
 
 Dialogue Health has not provided any forward-looking guidance as the company has entered into an agreement to be 
 <a href="https://investors.dialogue.co/English/news/news-details/2023/Dialogue-to-be-Acquired-by-Sun-Life/default.aspx">
 acquired by financial services company Sun Life Financial
 </a>
 for a consideration of CAD 365 million (USD 270 million) or CAD 5.15 (USD 3.82) per share. The transaction is expected to close in Q4 2023. Post acquisition, Dialogue will delist from the Toronto Stock Exchange but will continue to operate as a standalone entity under the &ldquo;Sun Life Canada&rdquo; brand from its head office in Qu&eacute;bec. 
 
 
 
</div>

Dialogue

Grin offers telemedicine and remote monitoring services for orthodontic needs such as braces and teeth straightening. Patients can conduct self-scans (using a Grin device made available to patients in collaboration with 3M) which can be connected to their smartphones and share the feed with orthodontists to access dental solutions. The company plans to go to a subscription-based model after the pandemic. The app also encourages patients to have a 40-second check monthly and share the scan with a dentist in order to allow patients to regularly maintain their dental hygiene.Grin is the only Telehealth disruptor covered on the hub that provides virtual orthopaedic consultations.Funding and financialsIn April 2021, the New York-based teledental platform concluded a seed funding of USD 14 million, and the funds will be allocated to develop additional functionalities by building out its technology. The proceeds will also be used to scale up its team, expand its geographic footprint, and add doctors to the company’s orthodontic partner network.

Grin

Real-time collection of patients’ health-related data using any remote patient monitoring device combined with general telemedicine services to reduce readmission rates. 


A platform that facilitates the transmission of patient data to different locations for further evaluation and interpretation by medical specialists. 


A digital platform that offers specialty care services to address the specific needs of a patient or demographic, including consultations where patients are generally reluctant to meet practitioners face-to-face.

Primary care through virtual consultations for general health-related concerns using a digital platform or mobile app. 

Companies developing B2B software solutions for patient engagement, care navigation, practice management, and electronic health records integration to facilitate telehealth services for healthcare providers. 

IoT is used by most telehealth providers to operate virtual services

All telehealth players are involved in digital health via virtual offerings

Industry players offer varying degrees of personalization for each target audience

Some players offer technology and platforms to healthcare providers, converting physical-only services into virtual services

Specific telehealth offerings focus on diversity and inclusion, providing care to LGBTQ+ or BIPOC populations

Generative AI is used to streamline administrative tasks such as clinical note-taking

Embla

About EDGE

Contact Us

Resources

Area of Focus

Technology Research Made Effortless